Passa al contenuto
Merck
Tutte le immagini(5)

Documenti

B0753

Sigma-Aldrich

2,3-Butanedione monoxime

≥98% (GC), powder, ATP-sensitive K⁺ and Ca²⁺ channel inhibitor

Sinonimo/i:

BDM

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Formula condensata:
CH3C(=NOH)COCH3
Numero CAS:
Peso molecolare:
101.10
Beilstein:
605582
Numero CE:
Numero MDL:
Codice UNSPSC:
12352200
ID PubChem:
NACRES:
NA.77

product name

2,3-Butanedione monoxime, ≥98%

Saggio

≥98%

Forma fisica

powder

P. eboll.

185-186 °C (lit.)

Punto di fusione

75-78 °C (lit.)

Stringa SMILE

CC(=O)\C(C)=N\O

InChI

1S/C4H7NO2/c1-3(5-7)4(2)6/h7H,1-2H3/b5-3+
FSEUPUDHEBLWJY-HWKANZROSA-N

Informazioni sul gene

human ... KCNB1(3745)

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Applicazioni

2,3-Butanedione monoxime has been used:
  • in single-molecule myosin V motility assays
  • as an anesthetic in the approach of imaging transgenic animals
  • to reduce rigor tension in muscle fibres
  • as a media component for mice cardiomyocytes culture

Azioni biochim/fisiol

2,3-Butanedione monoxime is inhibitor of ATP-sensitive K+ and Ca2+ channels.
DRK1 is a delayed rectifier (Kv2.1) cloned K+ channel from rat brain with consensus sites for protein kinase-dependent phosphorylation that might be expected to be functionally regulated by phosphorylation. 2,3-Butanedione monoxime (BDM) chemically removes phosphate groups from many proteins, and its action on DRK1 channels was examined after expression of DRK1 cRNA in Xenopus oocytes. In two-microelectrode voltage-clamp experiments, the application of 2,3-Butanedione monoxime to the bath inhibited DRK1 current (ki = 16.6 mM, H = 0.96) rapidly and reversibly, with a time course similar to the time course of solution change within the bath. DRK1 current was inhibited at all potentials; the time course of current activation, deactivation and inactivation were unaffected by 2,3-Butanedione monoxime. In inside-out patch-clamp experiments, the application of 2,3-Butanedione monoxime to the cytoplasmic surface similarly inhibited channel activity rapidly and reversibly (ki = 10.7 mM, H = 1.01) in the absence of rephosphorylating substrates. These results are inconsistent with a phosphatase effect, because such an effect should be irreversible in cell-free, ATP-free patches. Instead, the results suggest that 2,3-Butanedione monoxime can inhibit DRK1 channels directly from inside or outside of the membrane.

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Dispositivi di protezione individuale

Eyeshields, Gloves, type N95 (US)


Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Deficiency of mouse mast cell protease 4 mitigates cardiac dysfunctions in mice after myocardium infarction
Wang Yunzhe, et al.
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease (2019)
A transgenic approach to live imaging of heparan sulfate modification patterns
Glycosaminoglycans, 253-268 (2015)
M L Riccio et al.
Circulation research, 84(8), 955-963 (1999-05-01)
Despite recent advances in our understanding of the mechanism for ventricular fibrillation (VF), important electrophysiological aspects of the development of VF still are poorly defined. It has been suggested that the onset of VF involves the disintegration of a single
Effect of strain on actomyosin kinetics in isometric muscle fibers
Siththanandan VB, et al.
Biophysical Journal, 90(10), 3653-3665 (2006)
Qing Lou et al.
American journal of physiology. Heart and circulatory physiology, 302(1), H262-H269 (2011-11-01)
Unlike other excitation-contraction uncouplers, blebbistatin has few electrophysiological side effects and has gained increasing acceptance as an excitation-contraction uncoupler in optical mapping experiments. However, the possible role of blebbistatin in ventricular arrhythmia has hitherto been unknown. Furthermore, experiments with blebbistatin

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.